Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

STO/ANNX stock hub

STO/ANNX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

STO/ANNXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

105.5M

Nasdaq Stockholm

Market data

Price

Recent price action with selectable time range.

STO/ANNXSTO/ANNX

—

Loading chart…

In the news

Latest news · STO/ANNX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E5.4

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-137.7

P25 n/aP50 n/aP75 n/a

ROIC-84.8

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All STO/ANNX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

144

Groups with data

Currency

SEK

Showing 144 of 144 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	SE
Employees	4
Employees Change	0%
Employees Change Percent	0
Enterprise value	SEK 88.5M
Exchange	Nasdaq Stockholm
Financial currency	SEK
First seen	2026-05-10
Industry	Biotechnology
Isin	SE0009664154
Last refreshed	2026-05-10
Market cap	SEK 105.5M
Price	SEK 14.95
Price currency	SEK
Sector	Healthcare
Sic	2834
Symbol	sto/ANNX
Website	https://annexinpharma.se

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-37.37%
EV Earnings	-2.24x
EV/FCF	-2.26x
FCF yield	-37.08%
Forward P/E	5.38x
P/B ratio	7.32x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	SEK -39.4M
Net Income Growth Years	1%
Profit Per Employee	SEK -9.9M
ROA	-71.5
Roa5y	-91.62
ROCE	-269.8
ROE	-137.7
Roe5y	-188.1
ROIC	-84.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-45.86%
Cagr3y	-37.37%
Cagr5y	-33.71%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	SEK 20M
Cash	SEK 17.1M
Current Assets	SEK 18.4M
Current Liabilities	SEK 5.6M
Equity	SEK 14.4M
Liabilities	SEK 5.6M
Long Term Assets	SEK 1.5M
Long Term Liabilities	SEK -1,000
Net Cash	SEK 17.1M
Net Cash By Market Cap	SEK 16.17
Net Cash Growth	-62.26%
Net Debt Equity	SEK -1.18
Tangible Book Value	SEK 14.3M
WACC	5.92

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.31
Net Working Capital	SEK -4.2M
Quick ratio	3.2
Working Capital	SEK 12.9M

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-45.83%
200-day SMA	21.62
3Y total return	-75.44%
50-day SMA	14.39
50-day SMA vs 200-day SMA	50under200
5Y total return	-87.2%
All Time High	1,320
All Time High Change	-98.87%
All Time High Date	2017-09-22
All Time Low	11.65
All Time Low Change	28.33%
All Time Low Date	2026-04-13
ATR	0.8
Beta	0.3
Beta1y	0.58
Beta2y	0.33
Ch YTD	-24.49
High	15.7
High52	41.2
High52 Date	2025-05-19
High52ch	-63.71%
Low	14.95
Low52	11.65
Low52 Date	2026-04-13
Low52ch	28.33%
Ma50ch	3.9%
Price vs 200-day SMA	-30.86%
RSI	52.25
RSI Monthly	35.64
RSI Weekly	39.22
Sharpe ratio	-0.51x
Sortino ratio	-0.73
Tr YTD	-24.49
Tr1m	11.57%
Tr1w	-1.32%
Tr3m	-5.97%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SEK -38.9M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,558,347%
Shares Insiders	48.35%
Shares Institutions	8.89%
Shares Out	7,059,096

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	SEK -39.1M
Average Volume	8,664.85x
CAPEX	SEK -129,000
Ch1m	11.57
Ch1w	-1.32
Ch1y	-45.83
Ch3m	-5.97
Ch3y	-86.41
Ch5y	-92.91
Ch6m	-43.37
Change	-3.24%
Change From Open	-4.78
Close	15.45
Days Gap	1.62
Depreciation Amortization	194,500
Dollar Volume	32,725.6
Earnings Date	2026-05-13
EBIT	SEK -38.9M
EBITDA	SEK -38.7M
F Score	1
FCF	SEK -39.1M
FCF EV Yield	-44.23x
FCF Per Share	SEK -5.54
Financing CF	10,970,000
Fiscal Year End	December
Founded	2,014
Investing CF	-129,000
Is Primary Listing	1
Last Earnings Date	2026-02-06
Last Report Date	2026-03-31
Last Split Date	2025-05-28
Last Split Type	Reverse
Ma150	19.3
Ma150ch	-22.53%
Ma20	14.57
Ma20ch	2.61%
Net CF	-28,161,000
Next Earnings Date	2026-05-13
Open	15.7
Position In Range	0
Ppne	1,093,000
Price Date	2026-05-08
Ptbv Ratio	7.39
Relative Volume	0.25x
Tr6m	-43.37%
Volume	2,189

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does STO/ANNX pay a dividend?

Capital-return profile for this ticker.

Performance

STO/ANNX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns STO/ANNX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+8.9%

Share of float held by funds and institutions

Insider ownership

+48.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

STO/ANNX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.3

Neutral momentum band

Price vs 200-day MA

-30.9%

50/200-day relationship not available

Beta (5Y)

0.30

Less volatile than the market

Sharpe ratio

-0.51

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About STO/ANNX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sto/ANNX stock rating?

sto/ANNX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sto/ANNX analysis?

The full report lives at /stocks/sto/ANNX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sto/ANNX?

The latest report frames sto/ANNX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sto/ANNX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.